Company intelligence / Profile preview

inXso

Ownership: Private
Development stage: Other

Overview

inXso is an innovation agency that bridges the gap between medical research and international commercialization for healthcare technologies. It specializes in supporting innovators with business development, regulatory strategy (QARA), clinical design preparation, market entry strategies—especially for high-risk medical devices and advanced therapies—and integration of AI into medtech solutions. The company works with startups to scale-ups globally to accelerate the adoption of breakthrough technologies into healthcare systems

Modalities: Medical devicesIn vitro diagnosticsDigital health solutionsCell and gene therapiesNanomedicine
Industry: Consulting

Partnerships

European Innovation Council (EIC) partner for internationalization programs such as T2M venture building programme and EIC Access+ Open Call

Beyond the preview

Go deeper on inXso.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inXso.

Explore the full profile